Exendin-4 improves ER stress-induced lipid accumulation and regulates lipin-1 signaling in HepG2 cells

Cell Stress Chaperones. 2018 Jul;23(4):629-638. doi: 10.1007/s12192-017-0872-z. Epub 2018 Jun 22.

Abstract

Lipin-1 performs dual function during lipid metabolism, i.e., it functions as a transcriptional coactivator and as a phosphatidate phosphatase during triglyceride biosynthesis. We investigated whether exendin-4 prevented endoplasmic reticulum (ER) stress-induced hepatic steatosis and whether the protective effects of exendin-4 were associated with lipin-1 signaling. Tunicamycin and thapsigargin, ER stress inducers, increased triglycerides (TG) content and expression of genes encoding lipid droplet surface proteins. Exendin-4 decreased the expression of ER stress markers phosphorylated PKR like ER kinase (PERK), phosphorylated inositol-requiring enzyme 1 alpha (IRE1α), and glucose-regulated protein 78 kDa (GRP78) proteins and spliced X-box binding protein 1 (XBP-1s) mRNA and increased the expression of genes encoding lipolytic enzymes hormone-sensitive lipase (HSL) and monoacylglycerol lipase (MGL) and VLDL assembly-associated proteins microsomal triglyceride transfer protein (MTP) and apolipoprotein B (APOB) in tunicamycin-pretreated cells. Moreover, exendin-4 significantly decreased lipin-1β/α ratio by increasing SFRP10 and increased lipin-1 nuclear localization. The decrease in lipin-1β/α ratio was also observed in SIRT1 and AMPK agonist-treated cells. These data suggest that exendin-4 improves ER stress-induced hepatic lipid accumulation by increasing lipolysis and VLDL assembly, which is partially mediated by the regulation of lipin-1 signaling.

Keywords: ER stress; Exendin-4; Lipid accumulation; Lipin-1; Lipolysis; VLDL assembly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylate Kinase / metabolism
  • Apolipoproteins B / metabolism
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Endoplasmic Reticulum Chaperone BiP
  • Endoplasmic Reticulum Stress / drug effects*
  • Exenatide / pharmacology*
  • Hep G2 Cells
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism
  • Humans
  • Lipid Metabolism / drug effects*
  • Lipolysis / drug effects
  • Lipoproteins, VLDL / metabolism
  • Phosphatidate Phosphatase / metabolism*
  • Signal Transduction* / drug effects
  • Sirtuin 1 / metabolism
  • Tunicamycin / pharmacology

Substances

  • Apolipoproteins B
  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human
  • Lipoproteins, VLDL
  • Tunicamycin
  • Exenatide
  • Adenylate Kinase
  • LPIN1 protein, human
  • Phosphatidate Phosphatase
  • Sirtuin 1